Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Non-invasive biomarkers for early diagnosis of pancreatic cancer risk: metabolite genomewide association study based on the KCPS-II cohort

Fig. 1Fig. 1

The network between metabolites and clinical/biochemical indicators in each SNP group. ALB albumin, ALP alkaline phosphatase, ALT alanine aminotransferase, AST aspartate aminotransferase, BIL bilirubin, BMI body mass index, BUN blood urea nitrogen, CHO total cholesterol, CRE creatinine, DBP diastolic blood pressure, FBS fasting blood sugar, GGT gamma-glutamyltransferase, HDL, high-density lipoprotein, LDL low-density lipoprotein, SBP Systolic blood pressure, TG Triglyceride, URIC uric acid, WBC white blood cell. Node presents metabolite or clinical/biochemical indicators; the edge between two nodes indicates a partial correlation. The color of the nodes represents the z-score when comparing the pancreatic cancer incidence and control groups. Positive and negative correlations are represented using light-red and light-blue edges. Thicker edges represent stronger correlations between the two metabolite levels

Back to article page